PCVX
$19.32
Vaxcyte
($1.08)
(5.29%)
PCVX
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.54)
Revenue:  $0.00 Mil
Wednesday
Feb 9
4:10 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PCVX reports earnings?
Beat
Meet
Miss

Where is PCVX's stock price going from here?
Up
Flat
Down
Stock chart of PCVX
Analysts
Summary of analysts' recommendations for PCVX
Score
Grade
Pivots
Resistance
$22.10
$21.47
$20.39

$19.76

Support
$18.68
$18.05
$16.97
Tweet
Growth
Description
Vaxcyte Inc.is a biopharmaceutical company develops vaccines for infectious diseases. It offers conjugate, pneumococcal conjugate and complex antigen-based vaccines. Vaxcyte Inc.is based in Foster City, California.